Mitophagy
Mitophagy is the selective degradation of mitochondria by autophagy.
Mitochondria are essential organelles that regulate cellular energy homeostasis and cell death. The removal of damaged mitochondria through autophagy, a process called mitophagy, is thus critical for maintaining proper cellular functions. Indeed, mitophagy has been recently proposed to play critical roles in terminal differentiation of red blood cells, paternal mitochondrial degradation, neurodegenerative diseases, and ischemia or drug-induced tissue injury.
Autophagy and mitophagy are important cellular processes that are responsible for breaking down cellular contents, preserving energy and safeguarding against accumulation of damaged and aggregated biomolecules.
Targets for Mitophagy
Products for Mitophagy
- Cat.No. Product Name Information
-
GC11720
17-AAG (KOS953)
BMS 722782, CP 127374, KOS 953, NSC 330507, Tanespimycin
17-AAG(Geldanamycin), a natural benzoquinone ansamycin antibiotic, is the first established inhibitor of Hsp90. -
GC10710
3-Methyladenine
3-MA
3-Methyladenine is a classic autophagy inhibitor.
-
GC45356
5-Aminolevulinic Acid (hydrochloride)
-
GC16267
6-Hydroxydopamine hydrobromide
6-hydroxy Dopamine, Oxidopamine, 2,4,5-Trihydroxyphenethylamine
6-Hydroxydopamine hydrobromide (6-OHDA) is a structural analogue of catecholamines, dopamine and noradrenaline, and exerts its toxic effects on catecholaminergic neurons. -
GC17234
ABT-737
ABT 737, ABT737
An inhibitor of anti-apoptotic Bcl-2 proteins -
GC10518
AICAR
Acadesine, AICA-Riboside, NSC 105823
AICAR (also called acadesine) is a purine nucleoside. -
GC10580
AICAR phosphate
AMPK activator
-
GC15706
Aspirin (Acetylsalicylic acid)
Acetylsalicylic Acid, NSC 27223, NSC 406186
A non-selective, irreversible COX inhibitor -
GC71423
ATTECs Degrader 1
ATTECs Degrader 1 (Compound MT1) is an ATTECs compound.
-
GC62135
BC1618
BC1618, an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling (via preventing activated pAmpkα from Fbxo48-mediated degradation).
-
GC10480
Betulinic acid
Lupatic Acid, NSC 113090
Betulinic acid is a natural pentacyclic triterpenoid compound and an inhibitor of eukaryotic topoisomerase I with an IC50 value of 5 μM. -
GC17683
Brefeldin A
Ascotoxin, BFA, Cyanein, Decumbin, Nectrolide, NSC 56310, NSC 89671, NSC 107456, NSC 244390, Synergisidin
Brefeldin A (BFA) is a fungal macrocyclic lactone and a potent, reversible inhibitor of intracellular vesicle formation and protein trafficking between the endoplasmic reticulum (ER) and the Golgi apparatus. -
GC17340
Carbamazepine
Inhibitor of neuronal voltage-gated Na+ channels
-
GC15083
Celastrol
Celastrol is a proteasome inhibitor with a potent and preferred inhibition of purified 20S proteasome with an IC50 of 2.5 μM.
-
GC32078
Clioquinol (Iodochlorhydroxyquin)
Iodochlorohydroxyquin, NSC 3531, NSC 74938
Clioquinol (Iodochlorhydroxyquin) (Iodochlorhydroxyquin) is a topical antifungal agent with anticancer activity. -
GC30360
Cresol (Cresol mixture of isomers)
-
GC14787
Curcumin
Indian Saffron, Turmeric yellow
A yellow pigment with diverse biological activities -
GC40226
Curcumin-d6
Curcumin-d6 is intended for use as an internal standard for the quantification of curcumin by GC- or LC-MS.
-
GC13554
Deferoxamine mesylate
Ba 33112, DFO, DFOM, DFX, NSC 644468
Deferoxamine mesylate is a drug that chelates iron by forming a stable complex that prevents the iron from entering into further chemical reactions, and is used for the treatment of chronic iron overload in patients with transfusion-dependent anemias.
-
GC40775
Dexamethasone
MK-125, NSC 34521
Dexamethasone, as one member of the glucocorticoid family, can protect against arthritis-related changes in cartilage structure and function, including matrix loss, inflammation and cartilage viability.
-
GC11237
Dexamethasone acetate
NSC 39471
IL Receptor modulator
-
GC71260
Dox-btn2
Dox-btn2 is a biotinylated derivative of Doxorubicin , with a biotin label at the point of conjugation to doxorubicin at 3'-NH2.
-
GC13443
Doxazosin Mesylate
UK 33274-27
α1-adrenergic receptor antagonist -
GC16994
Doxorubicin
Hydroxydaunorubicin
Doxorubicin(DOX), also known as adriamycin, is a compound of the anthracycline class that has the broadest spectrum of activity.
-
GC17567
Doxorubicin (Adriamycin) HCl
DOX
Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. -
GC14968
Esmolol HCl
ASL 8052
Esmolol HCl is a beta adrenergic receptor blocker. -
GC15617
Etoposide
VP-16; VP-16-213
Etoposide (VP-16) is a nonspecific inhibitor of topoisomerase II with an IC50 value of 59.2μM. -
GN10156
Ginsenoside Rb1
Gypenoside III, NSC 310103
-
GC18049
GSK2578215A
LRRK2 inhibitor
-
GA10942
H-D-Gln-OH
D-Gln
-
GC14591
Hemin chloride
Hemin chloride, a substrate of heme oxygenase (HO)-1, induces HO-1 expression on a variety of cells to exert anti-oxidant and anti-inflammatory roles.
-
GC16105
Iohexol
contrast agent
-
GC12017
Isoniazid
Isonicotinylhydrazide, NSC 9659
antibiotic used for the treatment of tuberculosis -
GC64098
Isoniazid-d4
-
GC12339
Ivermectin
22,23-dihydro Avermectin B1, L-640,471, MK-933
NAChR/purinergic P2X4 receptor modulator -
GC38150
Liensinine Diperchlorate
Liensinine Diperchlor?ate is a major isoquinoline alkaloid, extracted from the seed embryo of Nelumbo nucifera Gaertn.
-
GC17874
Matrine
NSC 146051, NSC 318810
Matrine is an alkaloid found in Sophora japonica plants that acts as a kappa opioid receptor and µ-receptor agonist. -
GC10200
Mdivi 1
Mitochondrial Division Inhibitor 1
Mdivi-1 (Mitochondrial division inhibitor 1) inhibits traumatic brain injury (TBI)-induced dynamin-related protein 1(Drp1) up-regulation, autophagy dysfunction and mitophagy activation. -
GC15618
Melatonin
NSC 56423, NSC 113928, Regulin
Melatonin receptors agonist
-
GC60241
Melatonin D5
An internal standard for the quantification of melatonin
-
GC61045
Metformin D6 hydrochloride
1,1-Dimethylbiguanide hydrochloride-d6
An internal standard for the quantification of metformin -
GC17443
Metformin HCl
1,1-Dimethylbiguanide hydrochloride
Metformin HCl (1,1-Dimethylbiguanide hydrochloride) inhibits the mitochondrial respiratory chain in the liver, leading to activation of AMPK, enhancing insulin sensitivity for type 2 diabetes research. -
GC71451
MTX115325
MTX115325 (Example 1) is an orally active, brain-penetrating USP30 inhibitor (IC50=12 nM) with neuroprotective activity.
-
GN10257
Naringin
NSC 5548
-
GC12495
Olanzapine
LY170053
Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM). -
GC61809
Olanzapine D3
Olanzapine D3 (LY170053-d3) is the deuterium labeled Olanzapine.
-
GC17580
Olaparib (AZD2281, Ku-0059436)
AZD 2281, Ku0059436
Olaparib (AZD2281, Ku-0059436) is a potent and selective PARP inhibitor that specifically targets PARP1 and PARP2 (IC 50 = 5 nM and 1 nM, respectively). -
GC30871
Oxidopamine hydrochloride (6-Hydroxydopamine hydrochloride)
Oxidopamine hydrochloride (6-Hydroxydopamine hydrochloride) (6-OHDA) is an antagonist of the neurotransmitter dopamine.
-
GC38562
P62-mediated mitophagy inducer
PMI
P62-mediated mitophagy inducer is a mitophagy regulator which activates mitophagy without recruiting Parkin or collapsing ΔΨm and retains activity in cells devoid of a fully functional PINK1/Parkin pathway. -
GC71203
PARL-IN-1
PARL-IN-1 is a potent PARL inhibitor with an IC50 value of 28 nM.
-
GN10357
Parthenolide
Parthenolide is an NF-κB inhibitor with IC50 values for Eca109, KYSE-510, SiHa and MCF-7 cells of approximately 10.3, 13.3, 8.42 and 9.54µM at 48h respectively.
-
GC11332
Pitavastatin
HMG-CoA reductase inhibitor
-
GC12116
Pitavastatin Calcium
Itabastatin, Itavastatin, NKS 104
Enzyme HMGCR inhibitor -
GC36930
Pitavastatin D4
NK-104 D4
Pitavastatin D4 (NK-104 D4) is deuterium labeled Pitavastatin. -
GN10331
Polydatin
Piceid, (E)-Piceid, (E)-Polydatin, trans-Polydatin, trans-Resveratrol-3-O-β-D-Glucopyranoside
-
GC15904
PP242
PP242; PP-242
PP242 (PP 242) is a selective and ATP-competitive mTOR inhibitor with an IC50 of 8 nM. PP242 inhibits both mTORC1 and mTORC2 with IC50s of 30 nM and 58 nM, respectively. -
GN10266
Quercetin
Quercetin is an important dietary flavonoid, present in vegetables, fruits, seeds, nuts, tea and red wine.
-
GC61227
Quercetin D5
Quercetin D5 is a deuterium labeled Quercetin. Quercetin, a natural flavonoid, is a stimulator of recombinant SIRT1 and also a PI3K inhibitor with IC50 of 2.4 μM, 3.0 μM and 5.4 μM for PI3K γ, PI3K δ and PI3K β, respectively.
-
GC61229
Quinacrine dihydrochloride
Quinacrine (Mepacrine) dihydrochloride is an orally bioavailable antimalarial agent, which possess anticancer effect both in vitro and vivo.
-
GC32768
Quinacrine dihydrochloride (Mepacrine dihydrochloride)
-
GC14553
Resveratrol
(E)Resveratrol
Resveratrol (trans-Resveratrol; SRT501) is a phytoalexin. -
GC14191
Ruxolitinib (INCB18424)
INCB18424
Ruxolitinib (INCB018424), as an inhibitor, inhibits Janus-associated kinases (JAKs)JAK1 and JAK2 with IC50 values of 3.3 nM and 2.8 nM, respectively. -
GC16124
Ruxolitinib phosphate
INC 424 (phosphate), INCB 018424 (phosphate)
A potent and selective JAK1/JAK2 inhibitor -
GC16508
Salicylic acid
2-Hydroxybenzoic Acid, NSC 180
COX inhibitor -
GC74187
Salicylic acid-13C6
2-Hydroxybenzoic acid-13C6
Salicylic acid-13C6 is the 13C-labeled Salicylic acid. -
GC64032
Salicylic acid-d6
Salicylic acid-D6 (2-Hydroxybenzoic acid-D6) is a deuterium labeled Salicylic acid.
-
GC14882
Salinomycin
A selective cancer stem cell inhibitor
-
GC13595
SB 203580
SB 203580; RWJ 64809
SB 203580 is a specific inhibitor of p38-MAPK (Mitogen-activated Protein Kinase) pathway . -
GC13001
SB 203580 hydrochloride
PB 203580, RWJ 64809
Adezmapimod (SB 203580) hydrochloride is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2, respectively. -
GC10585
Simvastatin (Zocor)
MK-733, SVA
Simvastatin (Zocor) (MK 733) is a competitive inhibitor of HMG-CoA reductase with a Ki of 0.2 nM. -
GC31964
Sulfosuccinimidyl oleate
Sulfo-N-succinimidyl oleate
Sulfosuccinimidyl oleate (Sulfo-N-succinimidyl oleate) is a long chain fatty acid that inhibits fatty acid transport into cells.
-
GC34817
Sulfosuccinimidyl oleate sodium
SSO
A long chain fatty acid that inhibits fatty acid transport into cells
-
GC17651
Sunitinib
Sunitinib (SU 11248) is an orally active multi-target receptor tyrosine kinase inhibitor with IC50 values of 80 nM and 2 nM for vascular endothelial growth factor receptor (VEGFR2) and platelet-derived growth factor receptor (PDGFRβ), respectively.
-
GC48118
Sunitinib-d10
An internal standard for the quantification of sunitinib
-
GC45099
U-0126
A MEK inhibitor
-
GC15951
URB597
FAAH Inhibitor II, URB-597, URB 597, KDS-4103
An inhibitor of FAAH -
GC11424
Valproic acid
NSC 93819, 2-Propylvaleric Acid, Valproate, VPA
HDAC1 inhibitor -
GC15794
Valproic acid sodium salt (Sodium valproate)
2Propylvaleric Acid, Valproate, VPA
Valproic acid sodium salt (Sodium valproate) (VPA) is an orally active histone deacetylase (HDAC) inhibitor with an IC50 value of 1.5 mM. It inhibits HDAC1 with an IC50 value of 400 μM and can induce the degradation of HDAC2. -
GC64378
Valproic acid-d6
Valproic acid-d6 (VPA-d6) is the deuterium labeled Valproic acid. Valproic acid (VPA; 2-Propylpentanoic Acid) is an HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. Valproic acid activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. Valproic acid sodium salt is used in the treatment of epilepsy, bipolar disorder and prevention of migraine headaches.
-
GC17390
Vorinostat (SAHA, MK0683)
Suberoylanilide Hydroxamic Acid, Vorinostat
An HDAC inhibitor
-
GC71492
WJ-39
WJ-39 is an orally active aldose reductase (AR) inhibitor.